Explore the official voice of the IBMS - featuring our statements, white papers, consultation responses, policies, press releases, guidance and member publications
The IBMS welcomes the publication of the COVID-19 Inquiry’s Module 2 report which examines core decision-making, political governance and public health responses during the pandemic.
The Institute of Biomedical Science (IBMS), the Royal College of Pathologists (RCPath) and the Association for Laboratory Medicine (LabMed) have released a joint statement announcing a temporary pause in national quality assurance panel activities while a sustainable model is developed.
Developed by IBMS with Roche Diagnostics UK, with support from RCPath and LabMed, the report provides actionable guidance to improve standards, workforce capability and patient outcomes.
Investing in diagnostic capacity, digital transformation, and a robust biomedical science workforce is essential to delivering faster, more equitable elective care for all